Substance Withdrawal Syndrome
"Substance Withdrawal Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Descriptor ID |
D013375
|
MeSH Number(s) |
C25.775.835 F03.900.825
|
Concept/Terms |
Substance Withdrawal Syndrome- Substance Withdrawal Syndrome
- Substance Withdrawal Syndromes
- Syndrome, Substance Withdrawal
- Syndromes, Substance Withdrawal
- Withdrawal Syndrome, Substance
- Withdrawal Syndromes, Substance
Withdrawal Symptoms- Withdrawal Symptoms
- Symptom, Withdrawal
- Symptoms, Withdrawal
- Withdrawal Symptom
Drug Withdrawal Symptoms- Drug Withdrawal Symptoms
- Drug Withdrawal Symptom
- Symptom, Drug Withdrawal
- Symptoms, Drug Withdrawal
- Withdrawal Symptom, Drug
- Withdrawal Symptoms, Drug
|
Below are MeSH descriptors whose meaning is more general than "Substance Withdrawal Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Substance Withdrawal Syndrome".
This graph shows the total number of publications written about "Substance Withdrawal Syndrome" by people in this website by year, and whether "Substance Withdrawal Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 0 | 2 | 2 |
1996 | 2 | 1 | 3 |
1997 | 5 | 3 | 8 |
1998 | 7 | 0 | 7 |
1999 | 5 | 1 | 6 |
2000 | 3 | 1 | 4 |
2001 | 1 | 2 | 3 |
2002 | 3 | 2 | 5 |
2003 | 4 | 6 | 10 |
2004 | 3 | 4 | 7 |
2005 | 5 | 2 | 7 |
2006 | 12 | 3 | 15 |
2007 | 8 | 4 | 12 |
2008 | 12 | 3 | 15 |
2009 | 5 | 4 | 9 |
2010 | 6 | 6 | 12 |
2011 | 5 | 4 | 9 |
2012 | 9 | 3 | 12 |
2013 | 3 | 3 | 6 |
2014 | 7 | 1 | 8 |
2015 | 6 | 2 | 8 |
2016 | 4 | 3 | 7 |
2017 | 2 | 2 | 4 |
2018 | 5 | 2 | 7 |
2019 | 7 | 2 | 9 |
2020 | 2 | 2 | 4 |
2021 | 1 | 1 | 2 |
2022 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Substance Withdrawal Syndrome" by people in Profiles.
-
Treatment of Adolescent Cannabis Use Disorders. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):141-155.
-
Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study. Brain Stimul. 2022 Sep-Oct; 15(5):1206-1214.
-
The lateral habenula is not required for ethanol dependence-induced escalation of drinking. Neuropsychopharmacology. 2022 11; 47(12):2123-2131.
-
Examining Tobacco Treatment Perceptions and Barriers among Black versus Non-Black Adults Attending Lung Cancer Screening. Cancer Prev Res (Phila). 2022 05 03; 15(5):327-333.
-
Changes in striatal dopamine release, sleep, and behavior during spontaneous ?-9-tetrahydrocannabinol abstinence in male and female mice. Neuropsychopharmacology. 2022 07; 47(8):1537-1549.
-
Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial. Am J Psychiatry. 2021 09 01; 178(9):829-837.
-
Pain Status as a Predictor of Smoking Cessation Initiation, Lapse, and Relapse. Nicotine Tob Res. 2021 01 07; 23(1):186-194.
-
Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning. Psychopharmacology (Berl). 2020 Dec; 237(12):3653-3664.
-
Chronic intermittent ethanol and lipopolysaccharide exposure differentially alter Iba1-derived microglia morphology in the prelimbic cortex and nucleus accumbens core of male Long-Evans rats. J Neurosci Res. 2021 08; 99(8):1922-1939.
-
Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2020 05 01; 180(5):728-736.